| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 05/09/2001 | CN1294576A VLA-4 antagonists |
| 05/09/2001 | CN1294121A N-acyl amino-acid amide prodn. process |
| 05/08/2001 | US6229026 Reacting an isobenzofuran derivative with grignard reagents 4-halogen-fluorophenyl and 3-halogen-n,n-dimethylpropylamine; causing ring-closure of the product and conversion to 5-cyano derivative |
| 05/08/2001 | US6229011 N-aroylphenylalanine derivative VCAM-1 inhibitors |
| 05/08/2001 | US6228985 Derivatives of aminobenzoic and aminobiphenylcarboxylic acids useful as anti-cancer agents |
| 05/08/2001 | US6228982 Stable compounds that form double-stranded, helical structures mimicking double-stranded dna; diagnosis; prophylaxis; therapy; antisense agents |
| 05/03/2001 | WO2001030747A1 Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23 |
| 05/03/2001 | WO2001030745A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| 05/03/2001 | CA2389319A1 Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23 |
| 05/02/2001 | EP1095930A1 Novel compounds |
| 05/02/2001 | EP1095011A1 Novel fluorescent lanthanide chelates |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | EP0966427B1 Preparation of acid amides and metallisation of compounds |
| 05/02/2001 | EP0743853B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 05/02/2001 | CN1065237C Cyclopentane-and-cyclo pentene-beta-amino acids |
| 05/01/2001 | USRE37160 Synthesis of tyrosine derived diphenol monomers |
| 05/01/2001 | US6225625 Signal detection methods and apparatus |
| 05/01/2001 | US6225352 Low molecular weight dendritic compounds as pharmaceutical agents |
| 04/26/2001 | WO2001028982A1 Diethylenetriaminepenta acetic acid derivatives |
| 04/26/2001 | WO2001028979A2 Inhibitors of neuraminidases |
| 04/25/2001 | EP1094059A1 Process for production of N-acyl amino acid amide |
| 04/25/2001 | EP1093819A2 Compounds and compositions for delivering active agents |
| 04/25/2001 | EP0701568B1 New peptide derivatives |
| 04/25/2001 | CN1064954C Orthosubstituted benzoylguanidine, preparation of same, pharmaceutical containing same and application of same |
| 04/24/2001 | US6222052 Process for preparing optically active 2-amino-ω-oxoalkanoic acid derivatives |
| 04/24/2001 | US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase. |
| 04/24/2001 | US6221367 Exposing a biologically active agent to a complexing perturbant to reversibly transform the biologically active agent to the intermediate state and to form a transportable supramolecular complex |
| 04/22/2001 | WO2002102250A1 $g(in vivo) imaging |
| 04/22/2001 | CA2422767A1 In vivo imaging |
| 04/19/2001 | WO2000073274A3 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
| 04/19/2001 | WO2000050623A3 Method for preparing optically active 3,3,3-trifluoromethyl-2-alkyl propionic acid derivatives |
| 04/18/2001 | EP1091930A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 04/18/2001 | EP1091929A2 Secondary aspartic acid amide esters |
| 04/18/2001 | EP1091928A1 Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same |
| 04/18/2001 | CN1291973A N-sulphonyl and N-sulphinyl phenylglycinamide |
| 04/17/2001 | US6218393 Anthranilic acid derivatives as multi drug resistance modulators |
| 04/17/2001 | US6218370 Useful for cell transfection |
| 04/17/2001 | CA2103044C Novel bi-aromatic compounds derived from a salicylic pattern, method of preparation and use in human and veterinary medicine and in cosmetics |
| 04/12/2001 | WO2001025190A1 Novel diarylamide derivatives and use thereof as medicines |
| 04/12/2001 | WO2001025189A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds |
| 04/12/2001 | WO2001025172A1 A method for preparing and screening one or more compounds |
| 04/12/2001 | WO2001025170A1 N-SUBSTITUTED DIALKYL α-AMINO ACIDS FOR USE AS AMINO PROTECTING GROUPS |
| 04/12/2001 | WO2001024925A1 Method for activating passivated iron |
| 04/12/2001 | WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2 |
| 04/12/2001 | CA2385972A1 Novel diarylamide derivatives and use thereof as medicines |
| 04/12/2001 | CA2385715A1 A method for preparing and screening one or more compounds |
| 04/12/2001 | CA2385597A1 Method for activating passivated iron |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1090909A1 Novel inhibitors of prenylated pyrophosphate consuming enzymes |
| 04/11/2001 | EP1090625A2 Topical composition for the skin and use thereof |
| 04/11/2001 | EP1090106A2 Alkylamines and their precursors as specific modulators of human gamma-delta t cell function |
| 04/11/2001 | EP1089963A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
| 04/11/2001 | EP0809625B1 Anionic amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups based on dicarboxylic acid diamides |
| 04/10/2001 | US6214877 Antidiabetic agents; modulator of glucose concentration |
| 04/10/2001 | US6214799 Unsaturated amide compounds |
| 04/05/2001 | WO2001023347A1 Novel aromatic compounds |
| 04/05/2001 | WO2001023067A1 Polyamide-containing ligands covalently bonded to supports, polyamide-containing resins, and methods for removing metals from solutions |
| 04/05/2001 | DE19947508A1 Activation of passivated iron to form a catalyst component, useful for hydrogenation, comprises treatment with hydrogen at elevated temperature and pressure in the presence of a nitrile compound. |
| 04/05/2001 | DE19947457A1 New 2'-aminomethyl-biphenyl-2-carboxamide derivatives, are potassium channel blockers especially useful for treating re-entry or supraventricular arrhythmia or atrial fibrillation or flutter |
| 04/05/2001 | CA2384631A1 Polyamide-containing ligands covalently bonded to supports, polyamide-containing resins, and methods for removing metals from solutions |
| 04/04/2001 | EP1088481A2 Fungicides for the control of take-all disease of plants |
| 04/04/2001 | EP1087953A1 Nitrate salts of antihypertensive medicines |
| 04/04/2001 | EP1087940A1 Novel compounds useful in pain management |
| 04/04/2001 | EP1087938A1 Inhibitors of neuraminidases |
| 04/03/2001 | US6211245 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 04/03/2001 | US6211242 Benzamide derivatives as vasopressin antagonists |
| 03/29/2001 | WO2001021603A1 A process for the synthesis of ritonavir |
| 03/29/2001 | WO2001021584A1 Tyrosine derivatives |
| 03/29/2001 | WO2001021577A2 Melanin concentrating hormone antagonist |
| 03/29/2001 | WO2001021576A1 Aromatic diamide derivatives or salts thereof, agricultural/horticultural chemicals and method of using the same |
| 03/29/2001 | WO2000059875A3 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 03/29/2001 | CA2386474A1 Melanin concentrating hormone antagonist |
| 03/28/2001 | EP1086081A1 Quarternary ammonium compounds as anti-tussive agents |
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | EP1085845A2 Multibinding inhibitors of cyclooxygenase-2 |
| 03/28/2001 | EP1035772A4 Fungicidal compositions and methods, and compounds and methods for the preparation thereof |
| 03/28/2001 | CN1289324A Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound |
| 03/27/2001 | US6207712 Isolating or synthesizing fatty acid amino acid conjugate selected from n(17-hydroxylinolenoyl)-l-glutamine, n(linolenoyl)-l-glutamine; applying to plant such that plant produces and/or releases volatile compounds |
| 03/27/2001 | US6207693 Benzamide derivatives having a vasopressin antagonistic activity |
| 03/22/2001 | WO2001019809A1 Tryptase inhibitors |
| 03/22/2001 | WO2001019784A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 03/22/2001 | WO2001019780A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | CA2672722A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 03/22/2001 | CA2384763A1 Tryptase inhibitors |
| 03/21/2001 | EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/21/2001 | EP1085009A1 Indan derivatives |
| 03/21/2001 | EP1084137A1 Peptide inhibitors of hepatitis c virus ns3 protease |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |